orserdu
stemline therapeutics b.v. - elacestrant - bryst neoplasms - endokrin terapi - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.
ipreziv
takeda pharma a/s - azilsartan medoxomil - hypertensjon - agenter som virker på renin-angiotensinsystemet - ipreziv er indisert for behandling av essensiell hypertensjon hos voksne.
gaviscon
nordic drugs ab - natriumalginat / aluminiumhydroksid / natriumhydrogenkarbonat / kalsiumkarbonat - mikstur, suspensjon
kloramfenikol santen 5 mg/ ml
santen oy - kloramfenikol - Øyedråper, oppløsning i endosebeholder - 5 mg/ ml
mibg [123i] 74 mbq/ ml
curium netherlands b.v. - jobenguansulfat (123i) - injeksjonsvæske, oppløsning - 74 mbq/ ml
teriflunomide accord
accord healthcare s.l.u. - teriflunomide - multippel sklerose, relapsing-remitting - immunosuppressants, selektiv immunosuppressants - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
sporanox 100 mg
2care4 aps - itrakonazol - kapsel, hard - 100 mg